In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018–2020
Authors
Keywords
-
Journal
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-09-05
DOI
10.1016/j.jmii.2021.08.012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections
- (2021) Katie A Parsels et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A comprehensive assessment of carbapenem use across 90 Veterans Health Administration hospitals with defined stewardship strategies for carbapenems
- (2021) Hiroyuki Suzuki et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Epidemiology, Treatment, and Prevention of Nosocomial Bacterial Pneumonia
- (2020) Shio-Shin Jean et al. Journal of Clinical Medicine
- Pseudomonas aeruginosa sepsis presenting as oral ecthyma gangrenosum in identical twins with Bruton tyrosine kinase gene mutation: Two case reports and review of the literature
- (2020) Sheng-Chieh Lin et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- A Broken Antibiotic Market:Review of Strategies to Incentivize Drug Development
- (2020) Sujata M Bhavnani et al. Open Forum Infectious Diseases
- Impact of antibiotic timing on mortality from Gram-negative bacteraemia in an English district general hospital: the importance of getting it right every time
- (2020) Ioannis Baltas et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antimicrobial activities of ceftazidime–avibactam, ceftolozane–tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016
- (2019) Chun-Hsing Liao et al. Infection and Drug Resistance
- Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options
- (2019) Chau-Chyun Sheu et al. Frontiers in Microbiology
- Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis
- (2019) Xingran Du et al. AMERICAN JOURNAL OF INFECTION CONTROL
- In vitro activity of cefepime-enmetazobactam against Gram-negative isolates collected from United States and European hospitals during 2014-2015
- (2019) Ian Morrissey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cefiderocol: a promising antibiotic against multidrug-resistant Gram-negative bacteria
- (2019) Shio-Shin Jean et al. Expert Review of Anti-Infective Therapy
- Clinical characteristics and outcomes of community and hospital-acquired Acinetobacter baumannii bacteremia
- (2019) Sarunyou Chusri et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Comparative efficacy of doripenem versus meropenem for hospital-acquired and ventilator-associated pneumonia
- (2019) Wang-Da Liu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- The challenge of antimicrobial resistance: What economics can contribute
- (2019) Laurence S. J. Roope et al. SCIENCE
- Omadacycline: A Modernized Tetracycline
- (2019) Jason C Gallagher CLINICAL INFECTIOUS DISEASES
- An unusual community-acquired invasive and multi systemic infection due to ExoU-harboring Pseudomonas aeruginosa strain: Clinical disease and microbiological characteristics
- (2019) Alexandre Elabbadi et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Colistin for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex
- (2019) Jun-Yuan Zheng et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Changes in the resistance and epidemiological characteristics of Pseudomonas aeruginosa during a ten-year period
- (2019) Wei Feng et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- The clinical characteristics of Acinetobacter bacteremia differ among genomospecies: A hospital-based retrospective comparative analysis of genotypically identified strains
- (2019) Yusuke Koizumi et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Discovery and development of new antibacterial drugs: learning from experience?
- (2018) Nicole Jackson et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A multicenter study on clinical characteristics of Acinetobacter bacteremia in patients with liver cirrhosis
- (2018) Chang-Pan Liu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Severe community-acquired pneumonia due to Pseudomonas aeruginosa coinfection in an influenza A(H1N1)pdm09 patient
- (2018) I-Chia Su et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
- (2018) Evelina Tacconelli et al. LANCET INFECTIOUS DISEASES
- Introduction and geographic availability of new antibiotics approved between 1999 and 2014
- (2018) Cecilia Kållberg et al. PLoS One
- In vitro activities of cefiderocol, ceftolozane/tazobactam, ceftazidime/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan
- (2018) Shun-Chung Hsueh et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Activity of ceftolozane/tazobactam against surveillance and ‘problem’ Enterobacteriaceae, Pseudomonas aeruginosa and non-fermenters from the British Isles
- (2017) David M. Livermore et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- The threat of antimicrobial resistance in developing countries: causes and control strategies
- (2017) James A. Ayukekbong et al. Antimicrobial Resistance and Infection Control
- Activity of the Novel Extended-spectrum β-Lactamase Inhibitor AAI101 in Combination with Cefepime Towards a Challenge Panel of Acinetobacter baumannii
- (2017) Ian Morrissey et al. Open Forum Infectious Diseases
- Overproduction of active efflux pump and variations of OprD dominate in imipenem-resistant Pseudomonas aeruginosa isolated from patients with bloodstream infections in Taiwan
- (2016) Cheng-Yen Kao et al. BMC MICROBIOLOGY
- Emerging Resistance, New Antimicrobial Agents … but No Tests! The Challenge of Antimicrobial Susceptibility Testing in the Current US Regulatory Landscape
- (2016) R. M. Humphries et al. CLINICAL INFECTIOUS DISEASES
- Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the Ship
- (2016) Philippe Morency-Potvin et al. CLINICAL MICROBIOLOGY REVIEWS
- Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae
- (2016) Sarah M. Bartsch et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia
- (2016) Chang-Pan Liu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Influence of carbapenem resistance on mortality of patients with Pseudomonas aeruginosa infection: a meta-analysis
- (2015) Qianqian Liu et al. Scientific Reports
- Beyond serial passages: new methods for predicting the emergence of resistance to novel antibiotics
- (2011) José Luis Martínez et al. CURRENT OPINION IN PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now